F/m Emerald Life Sciences Innovation ETF Rating $27.78 +0.55 (+2.00%) Closing price 08/22/2025 03:19 PM EasternExtended Trading$27.78 0.00 (0.00%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.98Holdings in LFSC have an aggregate rating of Moderate Buy based on 254 analyst ratings issued in the past year covering 24 companies (88.6% of the portfolio).LFSC Aggregate Price Target$27.78High Prediction$27.78Average Prediction$27.78Low Prediction$27.78Holdings in LFSC have an aggregate price target of $27.78 and a range of $27.78 to $27.78 covering 24 companies (88.6% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.47%LIVNLivaNova$55.90+5.8%1.6896 of 5 stars3.00$59.71 6.8%8News CoveragePositive NewsAnalyst Forecast5.85%SLNOSoleno Therapeutics$68.57-1.8%4.5724 of 5 stars3.08$115.09 67.8%12News CoverageAnalyst ForecastAnalyst Revision5.68%TVTXTravere Therapeutics$17.92+0.7%2.4123 of 5 stars2.87$32.21 79.8%15News CoveragePositive NewsAnalyst Downgrade5.61%TMDXTransMedics Group$119.85+0.9%2.84 of 5 stars2.78$123.00 2.6%9News CoveragePositive News5.50%RDNTRadNet$70.10+2.2%3.3027 of 5 stars3.25$71.60 2.1%8News CoveragePositive NewsInsider Trade4.64%COLLCollegium Pharmaceutical$39.11-1.0%2.3481 of 5 stars3.00$42.33 8.2%3News CoveragePositive NewsInsider Trade4.32%KALVKalVista Pharmaceuticals$13.41+3.5%3.9022 of 5 stars3.11$26.29 96.0%94.29%MMSIMerit Medical Systems$89.45+3.3%4.4925 of 5 stars2.89$107.00 19.6%9Positive NewsAnalyst Revision3.88%BBIOBridgeBio Pharma$49.08-2.3%4.6761 of 5 stars3.00$61.35 25.0%17Insider Trade3.70%MDGLMadrigal Pharmaceuticals$414.68+1.9%3.5231 of 5 stars2.88$445.71 7.5%8News CoverageAnalyst ForecastInsider TradeAnalyst Revision3.63%CORTCorcept Therapeutics$70.33-0.9%4.7731 of 5 stars3.00$134.50 91.2%5Positive News3.54%WVEWAVE Life Sciences$10.15+4.0%4.7597 of 5 stars2.93$20.27 99.7%15Positive News3.52%GHGuardant Health$61.40+0.2%3.3505 of 5 stars3.06$57.50 -6.4%17News CoveragePositive News3.51%ETNB89BIO$9.43+2.6%2.0112 of 5 stars3.00$26.29 178.7%83.23%ATECAlphatec$16.14+1.3%3.9328 of 5 stars3.00$18.50 14.6%6Positive NewsInsider Trade3.05%INSMInsmed$131.88-0.5%4.0028 of 5 stars2.94$132.57 0.5%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.05%MIRMMirum Pharmaceuticals$71.52+3.6%3.4931 of 5 stars3.13$74.13 3.6%8News CoveragePositive News2.94%RAREUltragenyx Pharmaceutical$29.78+0.9%4.7276 of 5 stars2.92$81.50 173.7%12News Coverage2.88%COGTCogent Biosciences$12.12+3.0%3.6095 of 5 stars2.82$18.70 54.3%11Positive News2.11%ACADACADIA Pharmaceuticals$25.74+3.9%3.9433 of 5 stars2.61$28.88 12.2%18Positive NewsInsider Trade2.03%ITGRInteger$110.65+3.6%3.9582 of 5 stars3.00$140.25 26.8%9Positive News2.00%AXSMAxsome Therapeutics$118.51+1.2%4.7977 of 5 stars3.07$178.00 50.2%15News CoveragePositive News1.62%AKROAkero Therapeutics$49.23+1.9%4.0115 of 5 stars3.00$81.57 65.7%8News CoveragePositive News1.50%KRROKorro Bio$20.04-2.5%1.3233 of 5 stars3.29$86.83 333.3%7 This page (NASDAQ:LFSC) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access